James Kevin Hicks

James Kevin Hicks

H. Lee Moffitt Cancer Center & Research Institute - Tampa / United States
Others
AD Scientific Index ID: 4919885
person_outline James Kevin Hicks's MOST POPULAR ARTICLES
1-) Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake …JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, ...Clinical Pharmacology & Therapeutics 98 (2), 127-134, 20158502015
2-) Clinical pharmacogenetics implementation consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing: 2013 update.KTE Relling MV, Gardner EE, Sandborn WJ, Schmiegelow K, Pui CH, Yee SW ...Clinical Pharmacology & Therapeutics 93 (4), 324-5, 2013827*2013
3-) Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic AntidepressantsJK Hicks, JJ Swen, CF Thorn, K Sangkuhl, ED Kharasch, VL Ellingrod, ...Clinical Pharmacology & Therapeutics 93 (5), 402-408, 2013534*2013
4-) Clinical Pharmacogenetics Implementation Consortium Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Tricyclic AntidepressantsJK Hicks, JJ Swen, CF Thorn, K Sangkuhl, ED Kharasch, VL Ellingrod, ...Clinical Pharmacology & Therapeutics 93 (5), 402-408, 2013603*2013
5-) Landscape of EGFR-Dependent and -Independent Resistance Mechanisms to Osimertinib and Continuation Therapy Beyond Progression in EGFR-Mutant NSCLCX Le, S Puri, MV Negrao, MB Nilsson, J Robichaux, T Boyle, JK Hicks, ...Clinical Cancer Research 24 (24), 6195-6203, 20183562018